Short answer · Medically reviewed summary · Last updated: 2026-05-08
Pachyonychia Congenita (PC) is a rare genetic disorder characterized by hypertrophic nail dystrophy and painful palmoplantar keratoderma, with an estimated global prevalence of between 1 in 100,000 and 1 in 1,000,000. Because Pachyonychia Congenita is frequently underdiagnosed or misclassified as other skin conditions, these figures are considered conservative estimates rather than definitive counts. Is Pachyonychia Congenita considered a rare disease? Yes, Pachyonychia Congenita is classified as a rare disease.
What is the prevalence of Pachyonychia Congenita?
Prevalence of Pachyonychia Congenita: how many people are affected worldwide, differences by sex and region, with sources.
Pachyonychia Congenita (PC) is a rare genetic disorder characterized by hypertrophic nail dystrophy and painful palmoplantar keratoderma, with an estimated global prevalence of between 1 in 100,000 and 1 in 1,000,000. Because Pachyonychia Congenita is frequently underdiagnosed or misclassified as other skin conditions, these figures are considered conservative estimates rather than definitive counts.
Is Pachyonychia Congenita considered a rare disease?
Yes, Pachyonychia Congenita is classified as a rare disease. While the exact number of individuals living with the condition is difficult to track, the Pachyonychia Congenita Project (IPCRR) has registered over 1,000 individuals worldwide. The true prevalence likely exceeds current estimates because mild cases of Pachyonychia Congenita are often mistaken for simple nail fungus or common calluses, leading to significant under-reporting in clinical literature.
How does Pachyonychia Congenita affect different demographics?
Pachyonychia Congenita does not show a predilection for any specific gender, affecting males and females equally. Regarding age of onset, symptoms typically appear in infancy or early childhood, often manifesting as thickened nails or blisters on the feet as soon as a child begins to walk. While the condition is lifelong, the severity of symptoms can fluctuate.
What factors influence our understanding of Pachyonychia Congenita prevalence?
Several challenges complicate the epidemiological study of Pachyonychia Congenita:
- Genetic Heterogeneity: PC is caused by mutations in one of five genes (KRT6A, KRT6B, KRT6C, KRT16, or KRT17), which can lead to varying clinical presentations.
- Diagnostic Gaps: Due to the rarity of Pachyonychia Congenita, many primary care physicians may not recognize the condition, leading to misdiagnosis.
- Geographic Variation: There is no known ethnic or geographic predisposition, though reporting bias occurs in regions with robust genetic screening programs.
- Community Insights: At DiseaseMaps.org, 4 people with Pachyonychia Congenita have joined our community, providing vital real-world data that helps bridge the gap between clinical textbooks and lived experiences.
Next steps
- Consult a dermatologist with expertise in genodermatoses for a formal diagnosis.
- Consider genetic testing to identify the specific keratin mutation.
- Join the Pachyonychia Congenita Project (PC Project) to access patient resources and research updates.
- Connect with others at DiseaseMaps.org to share management strategies.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Pachyonychia Congenita.
- Orphanet: Rare disease database, Pachyonychia Congenita (ORPHA:676).
- OMIM (Online Mendelian Inheritance in Man): Entry #167200.
- The Pachyonychia Congenita Project (PC Project): International Patient Registry.
